Loading, please wait....jpg)
.jpg)
The Premier June 4, 2024 Antimicrobial Stewardship Forum will feature a continuing education (CE) activity from 12:00 - 1:00 PM EDT. We are pleased to provide knowledge-based, ACPE-accredited CE credit to pharmacists and pharmacy technicians during our webinar meetings.
Therapeutics for Respiratory Syncytial Virus (RSV): How Far We've Come
SPEAKER: Christine R. Lockowitz, PharmD, BCIDP, Pediatric Infectious Diseases Clinical Pharmacy Specialist, Pharmacy Director, St. Louis Children’s Hospital Antimicrobial Stewardship Program, St. Louis, MO
ACPE Universal Activity Number 0122-0000-24-013-L01-P [0.1 CEU] [1.0 Contact Hr]
Date: Jun 4, 2024 12:00 PM - 01:00 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Jun 04, 2024 12:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
CE participation will be provided to CPE Monitor within 45 days of the CE activity upon CE registration, confirmation of participation for the entire activity, and completion of online learning assessment questions and speaker evaluation administered post-session.
Objectives
- Describe the risk factors associated with severe RSV illness
- Recall the complications of RSV illness in both children and adults
- Review the available safety and efficacy data for therapeutics in the prevention of RSV in both children and adults
- Identify which patients qualify for an RSV vaccine
- Discuss the approach to preventing RSV in infants
Speaker(s)/Author(s)
|
Christine R. Lockowitz, PharmD, BCIDP
|
Activity Number
0122-0000-24-013-L01-P
Date:
06/04/24
Time:
12:00 PM - 01:00 PM
CE Hours
1.00